FIELD: organic chemistry. SUBSTANCE: product: substituted derivatives of purine arabinosides of the formula (I) where R1 halogen, methoxy, ethoxy, propoxy, amino-group which is monosubstituted with methyl or C-C -cycloalkyl, or disubstituted with C-C-alkyl, or R1 nitrogen-containing heterocycle; R2 hydrogen, halogen or amino-group at condition that when R2 hydrogen then R1 does not methoxy, methylamino, dimethylamino, piperidino or pyrrolidino-group, and when R2 amino-group then R1 does not methylamino-group, and/or its pharmaceutically acceptable derivatives, except for 2,3,5-triacetate and 2,3,5-tribenzyl-derivatives of the formula (I) where R1 chlorine or fluorine and R2 - chlorine, fluorine, hydrogen or amino-group. Reagent 1: compound of the formula (II) . Reagent 2: compound of the formula (III) . Synthesized compounds were used in medicine. EFFECT: improved method of synthesis.
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY AGAINST VIRAL INFECTION AND 9-β--D-ARABINOFURANOSYL-2-AMINO-6-METHOXY-9H-PURINES | 1993 |
|
RU2112765C1 |
MONO-, DI- OR TRICOMPLEX ESTERS OF 2-AMINO-6-(C-C-ALKOXY)-9-(β-D-ARABINOFURANOSYL)-9H-PURINE, METHOD OF THEIR SYNTHESIS, USING AND PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2114860C1 |
METHOD OF SYNTHESIS OF ENANTIOMERIC COMPOUNDS OR THEIR DERIVATIVES | 1990 |
|
RU2068849C1 |
METHOD OF SYNTHESIS OF 2'-DEOXY-2'-FLUORORIBONUCLEOSIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1990 |
|
RU2043361C1 |
ENANTIOMERIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1992 |
|
RU2091386C1 |
0 |
|
SU1779256A3 | |
METHOD OF IMIDAZOPYRIDAZINES SYNTHESIS | 1989 |
|
RU2017741C1 |
METHOD FOR PRODUCING 2,4-DIAMINO-5-(SUBSTITUTED) PYRIMIDINES | 0 |
|
SU1306473A3 |
METHOD FOR PRODUCING 2,4-DIAMINO-5-(SUBSTITUTED)PYRAMIDINES | 0 |
|
SU1318148A3 |
METHOD OF PYRIMIDINE NUCLEOSIDE SYNTHESIS | 1989 |
|
RU2036199C1 |
Authors
Dates
1995-07-20—Published
1988-07-04—Filed